Key Takeaways
- Summer portfolio drove the quarter: Navratna and Dermicool grew ~27%, contributing roughly 50% of domestic revenue, while the rest of the core portfolio was flattish as Kesh King, Male Grooming and Pain Management declined.
- Volume-led growth with margin tailwinds: 9% volume growth was aided by season and benign raw material costs, which expanded gross margin; management expects some full-year gross margin gains and a slight EBITDA margin uptick despite aggressive A&P spend.
- Kesh King remains the problem child: The premium hair-fall segment has been declining for some time, and Kesh King's sales swing with promotional cycles; management targets mid-single-digit growth ahead but admits the consumer bounce-back timing is uncertain.
- Strategic bets are scaling: The Man Company and Brillare are expected to reach ~INR275 crores (8% of revenue) this year and grow 20-25%, adding a premium digital layer to the portfolio.
- What to watch next quarter: Whether Kesh King and Fair and Handsome actually bounce back as promised, the pace of Pain Management recovery into winter, and how much of the summer portfolio's strength sustains post-season.
Portfolio Performance
- Summer portfolio (Navratna, Dermicool): Grew ~27% and contributed roughly 50% of domestic business revenue, helped by the hottest summer in 14 years. Management noted sales could have been higher with adequate supplies.
- Kesh King: Declined double digits as the premium hair-fall segment continued shrinking; sales are promotion-dependent, spiking during the two annual consumer and trade promotion windows. Shampoo is showing encouraging early response.
- Pain Management: Declined 7% because heatwaves suppressed demand during Q1; sales began picking up in June and are doing well in July, the peak season. A favourable winter base should aid recovery.
- Fair and Handsome / Male Grooming: Declined during the quarter; management says a long-term strategy is being worked on and expects growth to bounce back this quarter, though results will take at least one more quarter after the strategy is pulled out.
- International business: Achieved double-digit growth led by MENA and SAARC, driven by Navratna, Creme 21, 7 Oils in One and Kesh King, despite currency depreciation in Bangladesh and macro headwinds in CIS.
- General trade: Returned to positive territory. Rural demand showed gradual improvement with slight green shoots, though discretionary consumption was impacted by rising food prices and muted consumer confidence.
Mohan Goenka: "Kesh King has a pattern. In some quarters, it comes to growth, in some quarters, it declines depending on the consumer promotions and trade promotions that we offer."
Margins & Costs
- Gross margin: Expanded during Q1, driven by benign raw material prices, judicious price hikes taken last year and this year, and ongoing cost rationalization. Management expects some full-year gains.
- EBITDA margin: Should increase slightly for the full year despite higher advertising spend; A&P is expected to stay within 7-8% of sales, with 50-100 bps flexibility depending on need.
- Tax rate: Q1 saw a higher rate, but it should moderate; 10-11% is maintainable for the full year.
- Digital portfolio margins: Expected to improve going forward as The Man Company and Brillare scale.
Strategic Initiatives & New Launches
- Dermicool extensions: Launched Dermicool Her, the first prickly heat powder for women, and Dermicool Soap with superior cooling effects, initially in modern trade and e-commerce.
- Digital-first products: Introduced various digital-first products under the Kesh King and Zanducare portals.
- Zandu Dantveer: Launched 2-3 months back; physical rollout happened ~2 months back; still in the testing phase between e-commerce and modern trade.
- BCG engagement: Roped in BCG to develop a long-term strategy for Kesh King, with focus states including Maharashtra, Bihar and West Bengal where large competitors are present.
- Inorganic growth: Management is open to acquisitions as part of long-term strategy, with a strong balance sheet; first preference is India, but specific international market opportunities will also be considered. No specifics were disclosed.
Mohan Goenka: "Overall, the market for hair oil, particularly the premium hair fall segment, hair oil market is on a decline for quite some time now. So that we will have to see when the consumer bounces back, not very sure."
Demand & Volume Outlook
- Volume growth: Q1 delivered 9% volume growth, helped by season. Management expects 5-6% volume and 1-2% value growth going forward, and will not be very aggressive with price increases this year.
- Rural & regional trends: Uptick is broad-based; North is a little ahead, East is doing well, West is seeing modern trade expansion and channel shifts, South is steady.
- July demand: Quite good; monsoon is good in most parts of the country, and management sees a good demand cycle.
- Competitive intensity: Has come down a bit in the hair oil segment, particularly from Indulekha and Patanjali.
Mohan Goenka: "So we don't give guidance overall. We have to see how the monsoon or the winter performs. But yes the momentum is good."
Strategic Investments (The Man Company, Brillare)
- Scale: Expected to reach ~INR275 crores this year, roughly 8% of total revenues, with a growth target of 20-25%.
- Portfolio role: These are the premium-end brands; management does not formally segment the portfolio into premium and non-premium, but pegs the strategic investments at ~5.5-6% of revenue currently.
- Core volume ex-strategic investments: Volume growth for the core business alone was over 7% in Q1, per an analyst's math confirmed by management.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Kesh King growth | At least mid-single-digit growth going ahead; overall FY25 decline in range of 3-4% | FY25 full year |
| Kesh King & Fair and Handsome bounce-back | Growth bouncing back; "you will not see these kind of declines in both the categories" | This quarter (Q2 FY25) |
| The Man Company & Brillare revenue | Reach ~INR275 crores, ~8% of revenues, growing 20-25% | FY25 |
| Gross margin | Some benefits for the full year | FY25 |
| EBITDA margin | Increase "some bit" for the full year despite higher A&P | FY25 |
| Tax rate | 10-11% maintainable | FY25 full year |
| Healthcare growth | Double-digit growth going forward | Ongoing |
| Volume & value growth | 5-6% volume, 1-2% value growth | Ongoing |
Key Metrics
| Metric | Q1 FY25 |
|---|---|
| Revenue | Not stated as a single absolute figure; volume growth of 9% |
| Gross margin | 67.7%, grew by 230 bps YoY |
| EBITDA | ₹216 cr, grew by 14% YoY |
| EBITDA margin | Expanded by 90 bps YoY |
| Profit before tax | ₹128 cr, surged by 19% YoY with margins expanding by 160 bps |
| Profit after tax | ₹153 cr, grew YoY |
| A&P spends | 20.3% of sales, increased by 21% YoY |
| Volume growth (core business) | Over 7% (excluding strategic investments) |
| Domestic business volume growth | 9% |
| International business growth | 11% in constant currency terms, 10% in INR terms |
| Navratna and Dermicool growth | 27% |
| Healthcare range growth | 11% |
| 7 Oils in One growth | 9% |
| BoroPlus growth | 4% |
| The Man Company and Brillare growth | 23% |
| Pain Management range growth | Declined by 7% |
| Male Grooming range growth | Declined by 5% |
| Kesh King range growth | Declined by 15% |
| Modern trade growth | 25%, contributing 11% to domestic business |
| E-commerce growth | 29%, contributing 11% to domestic business |
| Institutional business growth | 23% |
| Summer portfolio growth | 27%, representing roughly 50% of domestic business revenue |
| The Man Company and Brillare revenue | ~₹225 cr combined, expected to reach ~₹275 cr in FY25, representing ~8% of total revenues |
| Kesh King portfolio size | Over ₹300 cr |
| Digital portfolio brands size | Around ₹25 cr |
| Tax rate guidance (FY25) | 10% to 11% |
| Amortization (FY25) | Roughly ₹92 cr |